New spinal implants under observation for back pain relief
NCT ID NCT06342765
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 330 adults who have received SpineVision spinal implants (Lumis, Plus, or Ulis) as part of their standard care for degenerative disc disease. Researchers will track pain, disability, and any side effects for up to 24 months after surgery to confirm the implants' safety and performance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SpineVision posterior fixation systems (Lumis, Plus, Ulis) implanted via pedicle fixation surgery
What this could lead to
If successful, this study could confirm that these spinal implants are safe and effective for treating degenerative disc disease, supporting their continued use.
What could go wrong
This is an observational study, not a controlled trial, so results may be less definitive. Risks include implant-related complications like infection or allergy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERVERTEBRAL DISC DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinique du dos Bordeaux-Terrefort
RECRUITINGBruges, 33520, France
Contact Email: •••••@•••••
-
DOSCEA Pôle Rachis
RECRUITINGBayonne, 64100, France
Contact Email: •••••@•••••
-
Orthéo Neurochirurgie
RECRUITINGSaint-Etienne, 42199, France
Contact Email: •••••@•••••